Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2012 Dec;52(12):1844-51.
doi: 10.1177/0091270011429566. Epub 2011 Dec 15.

Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study

Alice Panchaud  1 , Chantal Csajka, Paul Merlob, Christof Schaefer, Maya Berlin, Marco De Santis, Thierry Vial, Alessandra Ieri, Heli Malm, Georgios Eleftheriou, Bracha Stahl, Philippe Rousso, Ursula Winterfeld, Laura E Rothuizen, Thierry Buclin
Affiliations
Multicenter Study

Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study

Alice Panchaud et al. J Clin Pharmacol. 2012 Dec.

Abstract

Concerns have been raised about the use of topical retinoids since the publication of isolated cases of characteristic retinoid embryopathy, originally described after oral use. A collaborative study of the European Network of Teratology Information Services was carried out to evaluate the rate of congenital malformations following first-trimester topical retinoid exposure. A population of 235 exposed pregnant women was compared with 444 controls. No significant differences were observed between groups with regard to the rates of spontaneous abortion (odds ratio [95% confidence interval], 1.5 [0.8-2.7]), minor birth defects (1.3 [0.4-3.7]), and major birth defects (1.8 [0.6-5.4]). No child showed features of retinoid embryopathy. The rate of elective termination in the exposed group was increased 3-fold (3.4 [1.5-7.8]). In conclusion, these results do not suggest an increased risk of retinoid embryopathy. However, according to current knowledge, topical retinoids cannot be advised for use during pregnancy because their risk/benefit ratio remains questionable.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

LinkOut - more resources